In the above article [Bouyssou T, Casarosa P, Naline E, Pestel S, Konetzki I, Devillier P, and Schnapp A (2010) J Pharmacol Exp Ther 334:53–62], the authors have recently identified a mistake in the calculation of parts of the functional selectivity data in the originally published article. The selectivity data for olodaterol in the Abstract and in Table 3, and the selectivity ratios for formoterol, salmeterol, and isoprenaline in table 3 are incorrect in the original article.
In the Abstract and in Table 3, the correct olodaterol β2 selectivity ratios for the hβ1- and the hβ3-AR should be 241 and 2299, respectively. The corrected Table 3 is given below. Please note that the primary functional data underlying the calculations have not changed. Although the resulting newly calculated selectivity values are numerically different, the pharmacological assessment of olodaterol remains the same.
The online versions have been corrected.
The authors regret this error and apologize for any confusion and inconvenience it may have caused.
- Copyright © 2013 by The American Society for Pharmacology and Experimental Therapeutics